Abstract
Stereotactic body radiotherapy is an emerging treatment option for peripheral non-small cell lung cancer in medically inoperable patients. With high dose per fraction radiotherapy, late side effects are of possible concern. In our initial cohort of 42 patients treated with 54 to 60 Gy in three fractions, nine patients have rib fracture. The median dose to rib fracture sites was 46 to 50 Gy, depending on the method of dose calculation. We describe a typical case of poststereotactic radiotherapy rib fracture and present dosimetric analysis of patients with rib fracture.
| Original language | English |
|---|---|
| Pages (from-to) | 1035-1037 |
| Number of pages | 3 |
| Journal | Journal of thoracic oncology |
| Volume | 4 |
| Issue number | 8 |
| DOIs | |
| Publication status | Published - Aug 2009 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Keywords
- Non-small cell lung cancer
- Rib fracture
- Stereotactic body radiotherapy
Fingerprint
Dive into the research topics of 'Chest wall pain and rib fracture after stereotactic radiotherapy for peripheral non-small cell lung cancer'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver